Central Veterinary Institute of Wageningen UR (CVI), P.O. Box 65, 8200 AB Lelystad, the Netherlands.
Vaccine. 2011 Sep 16;29(40):6976-85. doi: 10.1016/j.vaccine.2011.07.037. Epub 2011 Jul 23.
Influenza A viruses lacking the gene encoding the non-structural NS1 protein (delNS1) have potential use as live attenuated vaccines. However, due to the lack of NS1, virus replication in cell culture is considerably reduced, prohibiting commercial vaccine production. We therefore established two stable MDCK cell lines that show inducible expression of the allele B NS1 protein. Upon induction, both cell lines expressed NS1 to about 1000-fold lower levels than influenza virus-infected cells. Nevertheless, expression of NS1 increased delNS1 virus titres to levels comparable to those obtained with an isogenic virus strain containing an intact NS1 gene. Recombinant NS1 expression increased the infectious virus titres 244 to 544-fold and inhibited virus induced apoptosis. However, NS1 expression resulted in only slightly, statistically not significant, reduced levels of interferon-β production. Thus, the low amount of recombinant NS1 is sufficient to restore delNS1 virus replication in MDCK cells, but it remains unclear whether this occurs in an interferon dependent manner. In contrast to previous findings, recombinant NS1 expression did not induce apoptosis, nor did it affect cell growth. These cell lines thus show potential to improve the yield of delNS1 virus for vaccine production.
缺乏编码非结构 NS1 蛋白的基因的甲型流感病毒(delNS1)有作为减毒活疫苗使用的潜力。然而,由于缺乏 NS1,病毒在细胞培养中的复制会大大减少,从而禁止了商业疫苗的生产。因此,我们建立了两种稳定的 MDCK 细胞系,这些细胞系可以诱导表达 B 型 NS1 蛋白等位基因。诱导后,两种细胞系均表达 NS1,其水平比感染流感病毒的细胞低约 1000 倍。然而,NS1 的表达将 delNS1 病毒滴度提高到与含有完整 NS1 基因的同源病毒株相当的水平。重组 NS1 表达将感染性病毒滴度提高了 244 至 544 倍,并抑制了病毒诱导的细胞凋亡。然而,NS1 的表达仅导致干扰素-β产生的水平略有降低,但统计学上无显著意义。因此,低水平的重组 NS1 足以恢复 MDCK 细胞中 delNS1 病毒的复制,但尚不清楚这是否以干扰素依赖的方式发生。与先前的发现相反,重组 NS1 表达既不会诱导细胞凋亡,也不会影响细胞生长。因此,这些细胞系有可能提高用于疫苗生产的 delNS1 病毒的产量。